# Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

> **NCT05928936** · PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 156 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Sodium Bicarbonate
- **BEHAVIORAL:** Exercise Training
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05928936
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-11
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05928936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05928936, "Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05928936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*